Created at Source Raw Value Validated value
June 27, 2024, 4 p.m. usa

1. female subjects who are pregnant or breastfeeding. 2. patients who are allergic to this medicine 3. patients allergic to content of study product 4. patients with diabetes. 5. patients accompanied by serious physical diseases of heart, lung, brain, etc. 6. patients have any condition that in the judgement of the investigators would make the subject inappropriate for entry into this study. 7. patients who are not able to take drugs orally.

1. female subjects who are pregnant or breastfeeding. 2. patients who are allergic to this medicine 3. patients allergic to content of study product 4. patients with diabetes. 5. patients accompanied by serious physical diseases of heart, lung, brain, etc. 6. patients have any condition that in the judgement of the investigators would make the subject inappropriate for entry into this study. 7. patients who are not able to take drugs orally.

Nov. 16, 2021, 6:30 p.m. usa

female subjects who are pregnant or breastfeeding. patients who are allergic to this medicine patients allergic to content of study product patients with diabetes. patients accompanied by serious physical diseases of heart, lung, brain, etc. patients have any condition that in the judgement of the investigators would make the subject inappropriate for entry into this study. patients who are not able to take drugs orally.

female subjects who are pregnant or breastfeeding. patients who are allergic to this medicine patients allergic to content of study product patients with diabetes. patients accompanied by serious physical diseases of heart, lung, brain, etc. patients have any condition that in the judgement of the investigators would make the subject inappropriate for entry into this study. patients who are not able to take drugs orally.

Oct. 26, 2020, 11:31 p.m. usa

1. female subjects who are pregnant or breastfeeding. 2. patients who are allergic to this medicine 3. patients allergic to content of study product 4. patients with diabetes. 5. patients accompanied by serious physical diseases of heart, lung, brain, etc. 6. patients have any condition that in the judgement of the investigators would make the subject inappropriate for entry into this study. 7. patients who are not able to take drugs orally.

1. female subjects who are pregnant or breastfeeding. 2. patients who are allergic to this medicine 3. patients allergic to content of study product 4. patients with diabetes. 5. patients accompanied by serious physical diseases of heart, lung, brain, etc. 6. patients have any condition that in the judgement of the investigators would make the subject inappropriate for entry into this study. 7. patients who are not able to take drugs orally.